BIOMEDICAL CATALYST FUND
Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-24 | Gripable | Biomedical Catalyst Fund investment in Grant - Gripable | 800 K GBP |
2022-03-30 | Invizius | Biomedical Catalyst Fund investment in Grant - Invizius | 1000 K GBP |
2021-02-18 | Vinehealth | Biomedical Catalyst Fund investment in Grant - Vinehealth | 1000 K GBP |
2019-07-10 | SleepCogni | Biomedical Catalyst Fund investment in Grant - SleepCogni | 234 K GBP |
2019-01-30 | MediSieve | Biomedical Catalyst Fund investment in Grant - MediSieve | 1.56 M GBP |
2014-05-01 | Calcivis | Biomedical Catalyst Fund investment in Grant - Calcivis | 1.3 M GBP |
2014-03-26 | Adaptimmune | Biomedical Catalyst Fund investment in Grant - Adaptimmune | 3.5 M USD |
2013-07-31 | Summit Therapeutics | Biomedical Catalyst Fund investment in Grant - Summit Therapeutics | 2.4 M GBP |
2013-05-30 | Atopix Therapeutics | Biomedical Catalyst Fund investment in Grant - Atopix Therapeutics | 1.7 M USD |
2012-11-06 | Arecor | Biomedical Catalyst Fund investment in Grant - Arecor | 785 K GBP |
More informations about "Biomedical Catalyst Fund"
Innovate UK - Biomedical Catalyst - Innovate UK Business Connect
Biomedical Catalyst is technology agnostic; we want to fund a variety of projects across different markets, technologies, strands and themes. How it works By awarding grants to UK-based โฆSee details»
Biomedical Catalyst Fund - Crunchbase Investor Profile
Biomedical Catalyst Fund may be growing as evidenced by the recent award of a £405K Innovate UK Biomedical Catalyst Grant to SolasCure, which is indicative of active investment in the โฆSee details»
Biomedical Catalyst | BIA - bioindustry.org
The BIA has been the driving force in making a compelling case for the interests of UK life science SMEs in Whitehall and Westminster. Your campaign to re-fund the Biomedical Catalyst, with โฆSee details»
Biomedical Catalyst 2024 Round 1: Industry-led R&D
Sep 2, 2024 The Biomedical Catalyst (BMC) was established in 2012 and identified a market failure in terms of access to funding for early-stage UK life sciences companies. Life Sciences โฆSee details»
Take on the biggest healthcare challenges: apply for โฆ
Jan 17, 2019 Since 2012, the Biomedical Catalyst has awarded over £250 million in grants to more than 300 projects. Previous projects include Calon Cardio and Swansea University, ...See details»
Biomedical Catalyst funding to boost healthcare innovation
Aug 22, 2024 Biomedical Catalyst is Innovate UKโs flagship grant funding mechanism helping small and medium-sized businesses test and develop innovative health and care solutions โฆSee details»
BIOMEDICAL CATALYST
The Biomedical catalyst was launched in 2012, with a provision of ล240m, for projects running until the end of 2014/15. Following an evaluation, a further ล100m was announced to fund โฆSee details»
Biomedical Catalyst Fund - Investments, Portfolio & Company Exits
Dec 16, 2022 Biomedical Catalyst Fund 's most notable exits include Immunocore, Summit Therapeutics, and Arecor. Which industries has this organization had the most exits in? Show โฆSee details»
Biomedical catalyst 2022 round two: industry-led R&D โ UKRI
Aug 4, 2022 UK registered micro, small or medium-sized enterprises (SME) can apply for a share of up to £25 million to develop innovative solutions to health and healthcare challenges.See details»
Biomedical Catalyst Fund - raizer.app
Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics. Learn which startups Biomedical Catalyst Fund invests in, number of โฆSee details»
Biomedical Catalyst 2023 Round 1: Industry-led R&D
Jan 4, 2023 The Biomedical Catalyst (BMC) was established in 2012 and identified a market failure in terms of access to funding for early-stage UK life sciences companies. Life Sciences โฆSee details»
Biomedical Catalyst Fund - Crunchbase
Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. โฆSee details»
£32 million boost for UK biomedical projects
Mar 26, 2015 A total of £350 million in funding has been invested in the Biomedical Catalyst since it was set up in 2011. This latest round of funding brings the total number of awards to โฆSee details»
Biomedical Catalyst 2024 Round One: Industry-Led R&D
Oct 9, 2024 The Biomedical Catalyst 2024 Round One: Industry-Led R&D funding opportunity is open to UK registered SMEs seeking funding to develop innovative solutions for health and โฆSee details»
Biomedical Catalyst 2022 Round 2: Industry-led R&D
Aug 15, 2022 The Biomedical Catalyst (BMC) was established in 2012, and identified a market failure in terms of access to funding for early stage UK life sciences companies. Life Sciences โฆSee details»
Biomedical Catalyst Funding Programe in the UK - fundsforNGOs
Deadline: 25-May-22 Innovate UK, part of UK Research and Innovation has announced Biomedical Catalyst funding programme to support UK businesses to test and develop โฆSee details»
Biomedical catalyst 2021: early and late stage awards
Jun 7, 2021 The Biomedical Catalyst (BMC) was established in 2012, and identified a market failure in terms of access to funding for early stage UK life sciences companies. Life Sciences โฆSee details»
List of Biomedical Catalyst Fund's 15 Investments ... - Crunchbase
List of Biomedical Catalyst Fund 's 15 Investments, including Alchemab Therapeutics and Gripable. Save Search . Companies . Contacts . Investors ...See details»
Exploring Manufacturing Techniques in Bioceramic Scaffold โฆ
Apr 3, 2025 Scaffolds are fabricated using a diverse range of materials, encompassing both natural and synthetic origins. These materials may include biodegradable polymers, ceramics, โฆSee details»
Great leaders in healthcare | 2025 | Becker's - Becker's Hospital โฆ
Mar 13, 2025 Arbuckleโs leadership of MemorialCareโs innovation fund has led to partnerships with over 50 companies, offering a valuable gateway to accelerate advances in healthcare โฆSee details»